Your browser doesn't support javascript.
loading
Pharmacological management of behavioral symptoms associated with dementia.
Madhusoodanan, Subramoniam; Ting, Mark Bryan.
Afiliação
  • Madhusoodanan S; Subramoniam Madhusoodanan, Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, NY 11203, United States.
  • Ting MB; Subramoniam Madhusoodanan, Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, NY 11203, United States.
World J Psychiatry ; 4(4): 72-9, 2014 Dec 22.
Article em En | MEDLINE | ID: mdl-25540722
ABSTRACT
Dementia is a clinical syndrome with features of neurocognitive decline. Subtypes of dementia include Alzheimer's, frontotemporal, Parkinson's, Lewy body disease, and vascular type. Dementia is associated with a variety of neuropsychiatric symptoms that may include agitation, psychosis, depression, and apathy. These symptoms can lead to dangerousness to self or others and are the main source for caregiver burnout. Treatment of these symptoms consists of nonpharmacological and pharmacological interventions. However, there are no Food and Drug Administration-approved medications for the treatment of behavioral and psychological symptoms of dementia. Pharmacological interventions are used off-label. This article reviews the current evidence supporting or negating the use of psychotropic medications along with safety concerns, monitoring, regulations, and recommendations.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article